$166.76+1.66 (+1.01%)
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States.
Globe Life Inc. in the Financial Services sector is trading at $166.76. Wall Street consensus targets $175.91 (11 analysts), implying a +5.5% move over the next 12 months. The stock is currently near its 52-week high of $168.27, remaining 17.4% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.56Bβ | $1.52Bβ | $1.51Bβ | $1.48B | $1.48B |
| Gross Profit | β | β | β | β | β |
| Operating Income | $365.84Mβ | $367.05Mβ | $513.24Mβ | $348.18Mβ | $351.07M |
| Net Income | $270.53Mβ | $266.08Mβ | $387.84Mβ | $252.75Mβ | $254.56M |
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States. It operates in three segments: Life Insurance, Supplemental Health Insurance...
Does Globe Life (GL) have what it takes to be a top stock pick for momentum investors? Let's find out.
GL is benefiting from premium growth, rising investment income and strong sales momentum across its insurance businesses.
Ross Stores, TE Connectivity, Cenovus Energy, Globe Life and Charles Schwab stand out for high ROE as investors navigate volatile markets.
MetLife, Globe Life, and Unum Group are hitting 52-week highs as P&C premiums decline, rewarding insurers with life, group benefits, and health exposure.
ROST joins TEL, CVE, GL and SCHW high-ROE cash cows screened for $1B+ cash flow as markets whip on Iran-U.S. skirmishes.